Skip to content

OS Therapies OSTX Market capitalization

Market capitalization at other companies

Immunome logo
ImmunomeIMNM
$2.47B+323%
CTO
Citius Oncology, Inc.CTOR
$54.72M-17.8%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$340.23M+298%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Computed from the period-end share price: $49.65M.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's market capitalization?
OS Therapies (OSTX) reported market capitalization of $49.65M in Q1 2026.
How has OS Therapies's market capitalization changed year-over-year?
OS Therapies's market capitalization increased by 48.1% year-over-year, from $33.52M to $49.65M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.